•
Jun 30, 2023

Inspire Q2 2023 Earnings Report

Reported a revenue increase of 65% year-over-year and provided updated 2023 outlook.

Key Takeaways

Inspire Medical Systems reported a strong second quarter with a 65% increase in revenue compared to the same quarter last year. The company also raised its full-year 2023 revenue guidance to between $600 million and $610 million.

Generated revenue of $151.1 million in the second quarter of 2023, a 65% increase over the same quarter last year

Achieved gross margin of 83.9% in the second quarter of 2023

Activated 72 new centers in the U.S. in the second quarter of 2023, bringing the total to 1,045 U.S. medical centers providing Inspire therapy

Created 19 new U.S. sales territories in the second quarter of 2023, bringing the total to 261 U.S. sales territories

Total Revenue
$151M
Previous year: $91.4M
+65.3%
EPS
-$0.41
Previous year: -$0.53
-22.6%
Total US Sales Territories
261
Total Centers
1.05K
New Center Adds
72
Gross Profit
$127M
Previous year: $77.2M
+64.3%
Cash and Equivalents
$467M
Previous year: $187M
+150.3%
Free Cash Flow
$237K
Previous year: -$7.37M
-103.2%
Total Assets
$618M
Previous year: $292M
+111.7%

Inspire

Inspire

Inspire Revenue by Geographic Location

Forward Guidance

Inspire is increasing its full year 2023 revenue guidance to between $600 million to $610 million, which would represent growth of 47% to 50% over full year 2022 revenue.

Revenue & Expenses

Visualization of income flow from segment revenue to net income